CYTOMED THERAPEUTICS LIMITED

Highlights CytoMed Therapeutics Limited

Equities

GDTC

SGXZ17669631

Market Closed - Nasdaq Other stock markets 21:30:00 22/05/2024 BST			5-day change	1st Jan Change
2.06 ^USD	+0.98%		-8.65%	-57.96%

04-22	CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-14	Certain Ordinary Shares of CytoMed Therapeutics Limited are subject to a Lock-Up Agreement Ending on 14-APR-2024.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	04-22	CI
CytoMed Therapeutics Limited to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies	03-18	CI
CytoMed Therapeutics Limited Announces Research Collaboration with Sengkang General Hospital Pte Ltd to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair	03-04	CI
CytoMed Therapeutics Receives Patent in Malaysia for its Prospective Cancer Therapy	01-29	MT
CytoMed Therapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2023	11-17	CI
CytoMed Therapeutics Limited Announces Entering into A Memorandum of Understanding with CNK Therapeutics Co., Ltd	29/08/23	CI
CytoMed Therapeutics Announces China Research Collaboration to Enhance Allogeneic CAR ?d T In Vivo Persistency	15/08/23	CI
CytoMed Therapeutics Granted US Patent for its Licensed CAR-Gamma Delta T Cell Technology	06/07/23	MT
CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-The-Shelf Gamma Delta T Cells in Oncology	09/05/23	CI
CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2022	01/05/23	CI
CytoMed Closes $9.65 Million Initial Public Offering	18/04/23	MT
CytoMed Therapeutic Shares Fall in Nasdaq Debut	14/04/23	MT
CytoMed Therapeutics Prices IPO at $4 per Share	14/04/23	MT
CytoMed Therapeutics Limited has completed an IPO in the amount of $9.649476 million.	13/04/23	CI
CytoMed Therapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2022	01/02/23	CI
CytoMed Therapeutics Limited has filed an IPO in the amount of $15 million.	18/11/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer